Since CSCs are considered as the major cause of treatment resistance and since our data showed that Orai3 is involved in chemoresistance in NSCLC tissues and cell lines, we thought to study the possible involvement of Orai3 in CSCs enrichment. Here, ORAI3 is linked to non-small cell lung carcinoma.